Related Experiment Video
Updated: Sep 18, 2025

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
Published on: June 2, 2022
Ischemic modified albumin and thiol levels in Coronavirus disease 19: a systematic review and meta-analysis
Asma Mousavi1,2, Shayan Shojaei1,2, Peyvand Parhizkar1
1School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Insights
Elevated ischemic-modified albumin (IMA) and reduced thiol levels are linked to COVID-19 severity. These oxidative stress markers may help predict patient prognosis and outcomes in the ongoing pandemic.
Area of Science:
- Biochemistry
- Clinical Medicine
- Epidemiology
Background:
- The COVID-19 pandemic presents a substantial global health challenge.
- Identifying prognostic markers is crucial for improving patient outcomes by mitigating morbidity and mortality.
- Oxidative stress indicators, such as ischemic-modified albumin (IMA) and thiol levels, are implicated in disease pathogenesis.
Purpose of the Study:
- To systematically review and meta-analyze the association between IMA and thiol levels in COVID-19 patients.
- To evaluate the relationship between these oxidative stress markers and COVID-19 disease severity and mortality.
Main Methods:
- A comprehensive literature search was conducted across major scientific databases (PubMed, Scopus, Embase, Web of Science).
- Original studies assessing IMA and thiol levels in COVID-19 patients were included.
- Random effect meta-analysis was used to calculate standardized mean differences (SMD) and confidence intervals (CI).
Main Results:
- Sixteen studies involving 2010 COVID-19 patients and 982 controls were analyzed.
- COVID-19 diagnosis correlated with significantly elevated IMA levels (Hedges's g = 1.02) and reduced total thiol levels (Hedges's g = -1.08).
- Subgroup analyses indicated lower total and native thiol levels in severe and critical COVID-19 cases, with higher IMA levels across moderate to critical disease stages.
Conclusions:
- Elevated IMA and diminished thiol levels show potential as novel prognostic markers for COVID-19 severity.
- These findings suggest oxidative imbalance plays a significant role in COVID-19 pathogenesis.
- Further research should explore therapeutic strategies targeting oxidative stress in COVID-19 patients.
Background:
The COVID-19 pandemic has imposed a significant global health burden. Identifying prognostic markers for COVID-19 and its severity could contribute to improved patient outcomes by reducing morbidity and mortality. This systematic review and meta-analysis aimed to evaluate the relationship between ischemic-modified albumin (IMA) and thiol levels, both indicators of oxidative stress, in patients diagnosed with COVID-19.
Method:
We conducted a comprehensive search across PubMed, Scopus, Embase, and Web of Science for eligible original studies. The study assessed IMA and thiol levels in COVID-19 patients, examining their association with both disease severity and mortality. A random effect analysis was conducted to estimate the standardized mean difference (SMD) and confidence intervals (CI).
Results:
Sixteen studies comprising 2010 COVID-19 patients and 982 controls were included. A diagnosis of COVID-19 was associated with significantly elevated IMA levels (Hedges's g = 1.02, 95% CI: 0.45 to 1.60) and reduced total thiol levels (Hedges's g = -1.08, 95% CI: -2.10 to -0.07). However, native thiol levels did not reveal a significant difference between infected patients and healthy participants. Subgroup analysis showed significantly lower total thiol levels in patients with critical and severe COVID-19, as well as lower native thiol levels specifically in critical COVID-19 patients. IMA levels were significantly higher across the critical, severe, and moderate COVID-19 groups.
Conclusion:
Elevated IMA and reduced thiol levels may serve as novel markers for predicting COVID-19 severity and prognosis. Further research is needed to explore therapeutic interventions that target oxidative imbalance in COVID-19 patients.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Coronary Syndrome III: Diagnostic Studies
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nephrotic Syndrome II : Assessment and Medical Management

